Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction

Ellen O Weinberg, Masahisa Shimpo, Gilles W De Keulenaer, Catherine MacGillivray, Shin-ichi Tominaga, Scott D Solomon, Jean-Lucien Rouleau, Richard T Lee, Ellen O Weinberg, Masahisa Shimpo, Gilles W De Keulenaer, Catherine MacGillivray, Shin-ichi Tominaga, Scott D Solomon, Jean-Lucien Rouleau, Richard T Lee

Abstract

Background: We identified an interleukin-1 receptor family member, ST2, as a gene markedly induced by mechanical strain in cardiac myocytes and hypothesized that ST2 participates in the acute myocardial response to stress and injury.

Methods and results: ST2 mRNA was induced in cardiac myocytes by mechanical strain (4.7+/-0.9-fold) and interleukin-1beta (2.0+/-0.2-fold). Promoter analysis revealed that the proximal and not the distal promoter of ST2 is responsible for transcriptional activation in cardiac myocytes by strain and interleukin-1beta. In mice subjected to coronary artery ligation, serum ST2 was transiently increased compared with unoperated controls (20.8+/-4.4 versus 0.8+/-0.8 ng/mL, P<0.05). Soluble ST2 levels were increased in the serum of human patients (N=69) 1 day after myocardial infarction and correlated positively with creatine kinase (r=0.41, P<0.001) and negatively with ejection fraction (P=0.02).

Conclusions: These data identify ST2 release in response to myocardial infarction and suggest a role for this innate immune receptor in myocardial injury.

Figures

Figure 1
Figure 1
Induction of soluble ST2 mRNA in cardiac myocytes. a, Induction of soluble ST2 mRNA by mechanical strain in NRCM. Northern analyses showing early (left) and later (right) time course. Maximal induction occurs at 2 hours, is sustained for 9 hours, and declines by 15 hours. b, Induction of soluble ST2 mRNA by mechanical strain, interleukin-1β (IL-1, 10 ng/mL), combined strain and interleukin-1β, and phorbol ester (PMA, 200 nmol/L) at 1 and 3 hours. Top, ST2 mRNA. Bottom, Ethidium bromide staining of 18S ribosomal RNA. No Str indicates no strain.
Figure 2
Figure 2
Nuclease protection assay demonstrating mRNA induction of soluble (Fit-1S) and membrane (Fit-1M) forms of ST2 in cardiac myocytes by mechanical strain. The expression of soluble ST2 mRNA is more abundant than membrane ST2 mRNA.
Figure 3
Figure 3
Activation of human ST2 promoter-luciferase constructs. a, Schematic representation of proximal and distal ST2 promoter region usage that gives rise to soluble and membrane ST2. Promoter usage is cell-type specific to produce a predominant transcript (indicated by thick lines) and a minor transcript (thin lines). b, 3.4-kb DNA flanking ST2 exon 1b (proximal promoter region) fused to luciferase reporter was responsive to interleukin-1β, mechanical strain, and phorbol ester. 2.1-kb DNA flanking ST2 exon 1a (distal promoter region) fused to luciferase reporter was slightly repressed by interleukin-1β, nonresponsive to mechanical strain, and weakly responsive to phorbol ester. *P < 0.05.
Figure 4
Figure 4
Serum ST2 levels in mice after MI. Serum ST2 levels were significantly increased 1 day after MI compared with sham-operated mice. Three days after MI, serum ST2 levels were similar among unoperated, sham-operated, and MI mice.
Figure 5
Figure 5
ST2 protein levels in the circulation of human patients after MI. Serial blood samples from 69 patients from the HEART study were analyzed for ST2 by ELISA. a, ST2 was significantly increased 1 day after MI compared with day 14 and day 90. b, Linear regression analysis demonstrating a significant positive relationship (P < 0.001) between circulating ST2 and creatine kinase 1 day after MI. Log ST2(ng/mL)=0.454[log CK(U/L)]−1.07. c, Linear regression analysis demonstrating a significant negative relationship (P = 0.02) between circulating ST2 and LV ejection fraction 1 day after MI.

References

    1. Iwahana H, Yanagisawa K, Ito-Kosaka A, et al. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur J Biochem. 1999;264:397–406.
    1. Bergers G, Reikerstorfer A, Braselmann S, et al. Alternative promoter usage of the fos-responsive gene Fit-1 generates RNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 1994;13:1176–1188.
    1. Tominaga S. A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin-1 receptor. FEBS Lett. 1989;258:301–304.
    1. Lohning M, Stroehmann A, Coyle AJ, et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci U S A. 1998;95:6930–6935.
    1. Coyle AJ, Lloyd C, Tian J, et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med. 1999;190:895–902.
    1. Prechtel D, Harbeck N, Berger U, et al. Clinical relevance of T1-S, an oncogene-inducible, secreted glycoprotein of the immunoglobulin superfamily, in node-negative breast cancer. Lab Invest. 2001;81:159–165.
    1. Kumar S, Minnich MD, Young PR. ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1. J Biol Chem. 1995;270:27905–27913.
    1. Gayle MA, Slack JL, Bonnert TP, et al. Cloning of a putative ligand for the T1/ST2 receptor. J Biol Chem. 1996;271:5784–5789.
    1. Dale M, Nicklin MJH. Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1/ST2), and IL18R1(IL-1Rrp) on human chromosome 2q. Genomics. 1999;57:177–179.
    1. Yamamoto K, Dang QN, Kennedy SP, et al. Induction of tenascin-C in cardiac myocytes by mechanical deformation. J Biol Chem. 1999;274:21840–21846.
    1. Feldman AM, Weinberg EO, Ray PE, et al. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 1993;73:184–192.
    1. Rohde LE, Ducharme A, Arroyo LH, et al. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation. 1999;23:3063–3070.
    1. Pfeffer MA, Greaves SC, Arnold MO, et al. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. Circulation. 1997;95:2643–2651.
    1. Solomon SD, Glynn RJ, Greaves S, et al. Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med. 2001;134:451–458.
    1. Aikawa Y, Rohde L, Plehn J, et al. Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysis. Am Heart J. 2001;141:234–242.
    1. Kuroiwa K, Li H, Tago K, et al. Construction of ELISA system to quantify human ST2 protein in sera of patients. Hybridoma. 2000;19:151–159.
    1. Takagi T, Yanagisawa K, Tsukamoto T, et al. Identification of the product of the murine ST2 gene. Biochim Biophys Acta. 1993;1178:194–200.
    1. Sadoshima J, Xu Y, Slayter HS, et al. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;5:977–984.
    1. Carter RW, Sweet MJ, Xu D, et al. Regulation of ST2L expression on T helper (Th) type 2 cells. Eur J Immunol. 2001;31:2979–2985.
    1. Gachter T, Werenskiold AK, Klemenz R. Transcription of the interleukin-1 receptor-related T1 gene is initiated at different promoters in mast cells and fibroblasts. J Biol Chem. 1996;271:124–129.
    1. Born TL, Smith DE, Garka KE, et al. Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. J Biol Chem. 2000;275:29946–29954.
    1. Reikerstorfer A, Holz H, Stunnenberg HG, et al. Low affinity binding of interleukin-1 β and intracellular signaling via NF-κB identify Fit-1 as a distant member of the interleukin-1 receptor family. J Biol Chem. 1995;270:17645–17648.
    1. Mitcham JL, Parnett P, Bonnert TP, et al. T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J Biol Chem. 1996;271:5777–5783.
    1. Mann DL. Stress activated cytokines and the heart. Cytokine Growth Factor Rev. 1996;7:341–354.
    1. St John Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000;101:2981–2988.
    1. O’Neill LAJ, Dinarello CA. The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol Today. 2000;21:206–209.
    1. Xu D, Chan WL, Leung BP, et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med. 1998;187:787–794.
    1. Yamaoka M, Yamaguchi S, Okuyama M, et al. Anti-inflammatory cytokine profile in human heart failure: behaviour of interleukin-10 in association with tumor necrosis factor-α. Jpn Circ J. 1999;63:951–954.
    1. Ohtsuka T, Hamada M, Hiasa G, et al. Effect of β-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2001;37:412–417.
    1. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med. 1999;5:1249–1255.
    1. Delves PJ, Roitt IM. The immune system. New Engl J Med. 2000;343:37–49.
    1. More SH, Breloer M, von Bonin A. Eukaryotic heat shock proteins as molecular links in innate and adaptive immune responses: Hsp60-mediated activation of cytotoxic T cells. Int Immunol. 2001;13:1121–1127.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera